Stock Market 25 April 2026

Intuit Stock Rebounds After AI Selloff as TurboTax Owner Nears Earnings Test

Shares of Intuit Inc. rebounded Friday, offering the TurboTax and QuickBooks parent a break after a steep slide sparked by Wall Street’s newest concern—AI pushing further into business software.

25 April 2026

Artificial Intelligence·Earnings Reports·NASDAQ:INTU·Stock Market

Intuitive Surgical Stock Rebounds As Da Vinci Robot Demand Gives ISRG Bulls A Fresh Test

Shares of Intuitive Surgical finished Friday in positive territory, pushing their rebound further after the company raised its 2026 growth forecast and flagged increased demand for its da Vinci surgical systems. According to LSEG data, the stock wrapped up April 24 at $482.22, climbing from $451.29 on April 21.

25 April 2026

NASDAQ:ISRG·Robotics·Stock Market

Ciena Stock Gets a BlackRock Filing as the AI Networking Trade Heats Up

BlackRock Inc. disclosed an 8.0% stake in Ciena Corporation—11.27 million shares—in an updated Schedule 13G filed Friday. According to the filing, those shares are held via various BlackRock business units and weren’t picked up with any intention to alter or direct control of the company.

25 April 2026

Artificial Intelligence·NASDAQ:CIEN·Stock Market·Technology

Why Eaton Corporation plc Stock Is Sitting Near Highs Before a Big AI Power Test

Eaton Corporation plc wrapped the week a hair under a new 52-week high, with investors still circling the power-management giant as AI and data center demand keeps electrical gear in focus. Shares on the NYSE slipped 0.14% Friday to finish at $423.92, off an intraday peak of $432.34. Market cap sits at roughly $164.5 billion, according to StockAnalysis.

25 April 2026

Artificial Intelligence·NYSE:ETN·Stock Market·Technology

Home Depot’s $4.3 Million Markdown Case Puts Retail Controls Back in Focus

A former Home Depot manager in Miami-Dade County is out of custody after authorities accused him of orchestrating a markdown scheme that reportedly drained about $4.3 million from the retailer, court and arrest records show. At issue: allegedly unauthorized price reductions — discounts below standard prices — on over 4,500 orders placed by recurring customers.

25 April 2026

NYSE:HD·Stock Market

Costco Wholesale’s Tariff Refund Fight Just Got Harder as Shoppers Seek Payback

Costco Wholesale is under renewed scrutiny in Washington, with House Democrats pressing the warehouse giant and other major firms to clarify whether refunds from overturned Trump-era tariffs will benefit shoppers—or just stay in corporate coffers.

25 April 2026

NASDAQ:COST·Stock Market

Palo Alto Networks Stock Jumps as AI Cyber Fears Become Its Next Big Test

Palo Alto Networks climbed 3.08% Friday to finish at $178.54, after hitting an intraday high of $179.10. Investors continued to grapple with worries about AI-powered cyber threats even as the company pours money into expanding its security platform. That’s per investor data from Palo Alto Networks.

25 April 2026

Artificial Intelligence·Cybersecurity·NASDAQ:PANW·Stock Market

Cameco Corporation Stock Faces a May 5 Test After Friday’s Uranium Pullback

Cameco Corp.’s U.S. shares slipped on Friday, taking some steam out of a strong run-up earlier in the week and shifting attention toward its upcoming earnings report. The NYSE-traded stock ended at $122.15, down $1.70. On the Toronto exchange, Cameco finished at C$167.02, a drop of C$2.45.

25 April 2026

Energy Sector·NYSE:CCJ·Stock Market

Cleveland-Cliffs Stock Snaps Back as Steel Turnaround Gets One More Test

Cleveland-Cliffs Inc. jumped 7.37% to $9.76 on Friday, with shares clawing back ground after a week spent digesting a first-quarter loss and management’s upbeat cash flow outlook. The steelmaker’s stock seesawed from $9.05 to $9.96 during the session before settling at its latest level.

25 April 2026

NYSE:CLF·Stock Market

PayPal Holdings Stock Gets a Pre-Earnings Lift, But Truist’s Sell Call Keeps Pressure On

Shares of PayPal Holdings climbed April 24 after Truist’s Matthew Coad bumped his price target up to $45 from $39, holding firm on his Sell rating. Coad pointed to a “mostly positive” payments landscape, referencing stronger U.S. bank numbers and more active consumer spending. Still, he told investors to “choose wisely.” PayPal finished the day at $50.48, up 1.47%—well ahead of Coad’s revised target.

25 April 2026

Earnings Reports·NASDAQ:PYPL·Stock Market

Buffett Is Off the Stage. Berkshire Hathaway’s Greg Abel Now Has to Answer

Berkshire Hathaway Inc. shareholders get their first look at Greg Abel in the chief executive seat next week, as he steps in for Warren Buffett at the company’s annual meeting. The spotlight shifts away from Buffett’s trademark stage presence as Abel faces investors still gauging his leadership. On May 2, Berkshire’s agenda has the Q&A kicking off at 9:30 a.m., another session at 11:45 a.m., with the formal meeting set for 2 p.m. Central in Omaha.

25 April 2026

NYSE:BRK.A·Stock Market

Coca-Cola Stock Faces a Big Week as World Cup Push Meets Earnings Test

Coca-Cola is set to report first-quarter results next week, bringing with it a new World Cup campaign and an early read from a major Latin American bottler—both factors that are putting a finer point on the question of whether demand will endure following multiple years of rising prices.

25 April 2026

Earnings Reports·NYSE:KO·Stock Market

3M Stock Rises After Profit Beat as Oil Costs Test 2026 Turnaround

3M Co. ended Friday up 0.79% at $145.99, with investors digesting a quarterly profit beat while management kept its 2026 outlook steady and flagged higher oil costs. That was the last price before the weekend; U.S. trading didn’t take place Saturday.

25 April 2026

Earnings Reports·NYSE:MMM·Oil Prices·Stock Market

Uranium Energy Corp Stock Slides 6% as New U.S. Uranium Mine Becomes the Real Test

Uranium Energy Corp. shares dropped roughly 6% on Friday, snapping back as traders reassessed the stock after a sharp run-up tied to U.S. uranium supply developments and the launch of the company’s Burke Hollow mine in South Texas.

25 April 2026

Energy Sector·NYSE:UEC·Stock Market

US Stock Market This Week: S&P 500, Nasdaq Hit Records as Intel Sparks AI Rally

The S&P 500 and Nasdaq both notched fresh record closes this week, thanks to a late-session surge in chip stocks after Intel’s upbeat forecast rekindled enthusiasm for the artificial-intelligence sector. The Dow lost ground, so beneath the surface, the rally was less broad than the headline highs implied.

25 April 2026

NASDAQ:AMD·NASDAQ:ARM·NASDAQ:INTC·NASDAQ:NVDA·Stock Market·Technology

Sirius XM Holdings Inc. Deal Talks With iHeartMedia Could Reshape U.S. Audio Market

Sirius XM Holdings Inc. and iHeartMedia Inc. are in early-stage merger discussions, Bloomberg News reported, eyeing a tie-up between the top U.S. satellite-radio firm and the nation’s largest radio-station group. These talks are still in the early phase and could stall without a deal, according to the report. Both Sirius and iHeartMedia told Reuters they wouldn’t comment.

25 April 2026

NASDAQ:SIRI·Stock Market

Shake Shack Stock Gets a Fresh Wall Street Boost Before Earnings. Here’s What Changed

• Guggenheim initiated coverage of Shake Shack with a Buy rating and set the price target at $120, joining a recent streak of upbeat analyst opinions.

25 April 2026

Earnings Reports·NYSE:SHAK·Stock Market

CRISPR Therapeutics Stock Just Lost 12%: What Casgevy Must Prove Next

CRISPR Therapeutics AG dropped 11.6% on Friday, finishing at $48.79—well below its $55.01 open—as investors bailed on the gene-editing drug developer. No new statements appeared on the investor site; the most recent update remains an April 7 conference listing.

25 April 2026

NASDAQ:CRSP·NASDAQ:VRTX·Stock Market

Intellia Therapeutics Stock Jumps After Hours Ahead of First Phase 3 In Vivo CRISPR Readout

Intellia Therapeutics is slated to release top-line results Monday from HAELO, its pivotal trial of lonvoguran ziclumeran—an experimental, one-and-done therapy aimed at hereditary angioedema. The company bills this as the first-ever Phase 3 data for an in vivo CRISPR gene-editing therapy, meaning the genetic tweak happens directly in the patient rather than in lab-modified cells.

25 April 2026

Biotechnology·NASDAQ:NTLA·Pharmaceutical News·Stock Market

Rivian’s R2 Moment Is Here, and Traders Are Betting the Next Move Could Be Sharp

Rivian Automotive has kicked off production on its R2 SUV, shifting its headline vehicle from concept to reality just days ahead of quarterly earnings. The new model comes in at a lower price, targeting a broader customer base beyond Rivian’s R1 lineup and taking direct aim at Tesla’s Model Y. CFO Claire McDonough told Reuters the company is “encouraged” by R2 reservations, though she didn’t share figures.

25 April 2026

Electric Vehicles·NASDAQ:RIVN·Stock Market·Technology